Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Trastuzumab Injection (Subcutaneous Injection)

Approval Number

国药准字SJ20220017

CompanyRoche Pharma (Schweiz) AG

Registration Date

September 30, 2022

Drug Information

Generic Name

曲妥珠单抗注射液(皮下注射)

Dosage Form

注射剂

Strength

600mg（5ml）/瓶

Drug Type

生物制品

Registration Date

September 30, 2022

Expiry Date

September 29, 2027

Company Information

Applicant Company

Company NameRoche Pharma (Schweiz) AG

Company Address

Gartenstrasse 9,4052 Basel,Switzerland

Manufacturing Company

Company NameF. Hoffmann-La Roche Ltd.

Company Address

Wurmisweg，4303 Kaiseraugst，Switzerland

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy